Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
$1.7 Million Bet On This Biotechnology Stock? 3 Penny Stocks Insiders Are Buying
U.S. stock futures traded higher this morning after recording losses in the previous session. Investors, meanwhile, focused on some notable insider trades.
EPIX: Encouraging Signs of Activity in Phase 1 Trial of EPI-7386…
By David Bautz, PhD
NASDAQ:EPIX
READ THE FULL EPIX RESEARCH REPORT
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics’ Tebipenem, Graybug Reviews Strategic Alternatives
Here's a roundup of top developments in the biotech space over the last 24 hours:
ESSA Pharma’s EPI-7386 Monotherapy / Combo Therapy Show Early Activity Against Prostate Cancer
ESSA Pharma Inc (NASDAQ:EPIX) presented clinical results from the Phase 1a dose-escalation study of EPI-7386 as a monotherapy for metastatic castration-resistant…